Primary prevention of cardiovascular disease in women

Area of Science:

• Cardiology
• Preventative Medicine
• Biomarkers

Background:

• Ischemic heart disease is the leading cause of cardiovascular disease (CVD) mortality globally.
• Traditional modifiable risk factors (hypertension, smoking, dyslipidemia, diabetes) are crucial but face persistent challenges in equitable access and education, especially for women.
• Female-specific risk factors (e.g., premature menopause, gestational hypertension) offer unique avenues for targeted CVD prevention.

Purpose of the Study:

• To review established and emerging strategies for improving cardiovascular disease (CVD) risk assessment in women.
• To discuss novel approaches for early disease detection and personalized preventative therapies.
• To highlight the need for targeted interventions to reduce the burden of CVD in women.

Main Methods:

• Review of established risk factors and challenges in CVD prevention.
• Exploration of female-specific risk factors and their association with CVD.
• Discussion of emerging technologies including blood-based 'omics', advanced imaging biomarkers, and bioinformatics for personalized medicine.

Main Results:

• Traditional risk factor management is essential but insufficient, particularly for women.
• Female-specific risk factors present opportunities for tailored prevention, though more research is needed.
• Novel 'omics' and bioinformatic approaches offer potential for personalized early detection and treatment, especially where traditional factors are less predictive.

Conclusions:

• Improving CVD risk assessment, early detection, and prevention in women requires addressing both traditional and female-specific factors.
• Personalized medicine approaches leveraging advanced biomarkers and analytics are crucial for reducing CVD burden in women.
• Further research is urgently needed to develop and validate specific screening tools and interventions for women.